TYK Medicines, Inc. Class H (2410) Income Statement

2 Followers

TYK Medicines, Inc. Class H Income Statement

Last quarter (Q2 2024), TYK Medicines, Inc. Class H's total revenue was ¥0.00, a decrease of ― from previous quarter. In Q2, TYK Medicines, Inc. Class H's net income was ¥-111.53M. See TYK Medicines, Inc. Class H’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 24	Dec 23	Dec 22
Total Revenue	¥ 107.00K	¥ 0.00	¥ 44.24M
Gross Profit	¥ 14.00K	¥ 0.00	¥ 20.04M
Operating Expenses	¥ 316.81M	¥ 286.24M	¥ 254.84M
Depreciation and Amortization	¥ 29.32M	¥ 27.64M	¥ 16.33M
EBITDA	¥ -346.03M	¥ -346.80M	¥ -292.22M
Operating Income	¥ -316.80M	¥ 0.00	¥ -234.79M
Other Income/Expenses	¥ -71.13M	¥ -383.17M	¥ -77.01M
Pretax Income	¥ -387.93M	¥ -383.17M	¥ -311.80M
Net Income	¥ -386.95M	¥ -382.43M	¥ -310.99M
Per Share Metrics
Basic EPS	¥ -1.15	¥ -1.03	¥ -0.84
Diluted EPS	¥ -1.15	¥ -1.03	¥ -0.84
Weighted Average Shares Outstanding	337.62M	370.84M	370.84M
Weighted Average Shares Outstanding (Diluted)	337.62M	370.84M	370.84M

Currency in CNY

TYK Medicines, Inc. Class H (2410) Income Statement

TYK Medicines, Inc. Class H Income Statement

TYK Medicines, Inc. Class H Earnings and Revenue History